Braeburn Wealth Management »

Tg Therapeutics shares owned by Braeburn Wealth Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Braeburn Wealth Management from 13F filings

Historical chart of Braeburn Wealth Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Braeburn Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Braeburn Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 21k 54.94

More positions owned by Braeburn Wealth Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Mega Cap Val Etf (MGV)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Gold Tr Ishares New (IAU)
Ishares Tr Core S&p Mcp Etf (IJH)
Apple (AAPL)
Invesco Exchange Traded Fd T S&p Mdcp Momntum (XMMO)
Fidelity Covington Trust Int Vl Fct Etf (FIVA)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Caterpillar (CAT)
Ishares Tr Russell 2000 Etf (IWM)
Spdr Series Trust St Str Sp Biot (XBI)
Simon Property (SPG)
Comfort Systems USA (FIX)

View all positions for Braeburn Wealth Management

Top funds holding Tg Therapeutics

BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Geode Capital Management
D. E. Shaw & Co
Soleus Capital Management
ClearBridge Advisors
Congress Asset Management
Two Sigma Investments
Jane Street
Goldman Sachs Group
Susquehanna International
Pictet Asset Management Holding SA
Nuveen

View all funds holding Tg Therapeutics